Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?

It has been about a month since the last earnings report for Jazz Pharmaceuticals (JAZZ) . Shares have lost about 3.9% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Jazz due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Jazz Pharmaceuticals PLC before we dive into how investors and analysts h ...